Cost-effectiveness of supplementary immunization for measles in India.
Indian Pediatr
;
2009 Nov; 46(11): 957-962
Artículo
en Inglés
| IMSEAR
| ID: sea-144214
ABSTRACT
Objective:
This study aims to estimate the incremental cost effectiveness of a supplementary immunization activity (SIA) for measles in a district of India with measles vaccine coverage equivalent to the National average.Design:
A state transition model is used to estimate the effect of routine vaccination with measles vaccine as well as with measles vaccine during the SIA. The model follows each sub-cohort in the target population at respective age (1-5 years) to five years of age, using age specific incidence rate and vaccination rate to determine the number of cases of measles. Using age specific incidence rates and complication rates for measles; deaths and disability adjusted life year (DALY) averted is estimated.Results:
Using base-case assumptions, an estimated 65479 cases of measles and 1637 deaths due to measles will be prevented in a span of four years from a single supplementary immunization activity in a pediatric population (1-5 years of age) of size 839,473. The cost per measles vaccine dose delivered is INR 30. Using base case analysis the cost to avert a death is INR 15381 and the cost per disability adjusted life year (DALY) averted is INR 430.Conclusions:
Supplementary immunization activity for measles is cost-effective. However, this cannot be considered superior to a second dose of measles in routine immunization.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Humanos
/
Árboles de Decisión
/
Vacuna Antisarampión
/
Preescolar
/
Estudios de Cohortes
/
Inmunización Secundaria
/
Análisis Costo-Beneficio
/
India
/
Lactante
/
Sarampión
Tipo de estudio:
Estudio de etiología
/
Evaluación Económica en Salud
/
Estudio de incidencia
/
Estudio observacional
/
Estudio pronóstico
/
Factores de riesgo
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian Pediatr
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS